Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial
Annane et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(23)00082-6
https://c19early.org/annane.html